The role of MIC-1 in cancer and inflammation

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Macrophage inhibitory cytokine-1 (MIC-1) participates in cancer, stroke and heart attack. Studies show that measurement of MIC-1 in blood and cancer tissue might be useful to detect the development of cancer and determine whether it will spread. Also, MIC-1 measurement can identify people who are at risk of dying of cancer, heart attack and stroke. This study will show how MIC-1 may be used to prevent, diagnose and help treat these conditions and reduce healthcare costs.

Funded Activity Details

Start Date: 01-01-2009

End Date: 01-01-2012

Funding Scheme: Career Development Fellowships

Funding Amount: $387,489.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Clinical sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Atherosclerosis | Cancer | Health outcomes | Inflammation | MIC-1